Re: Artificial Intelligence for Diagnosis and Grading of Prostate Cancer in Biopsies: A Population-based, Diagnostic Study

Affiliations

¹ Division of Urology, Department of Surgery, Sinai Health System, University of Toronto, Toronto, ON, Canada; Surgical Oncology, Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: alexandre.zlotta@sinaihealth.ca.
² Department of Computer Science, Faculty of Science, Ryerson University, Toronto, ON, Canada; Healthcare AI and Analytics Theme, Institute for Biomedical Engineering, Science, and Technology (iBEST), Toronto, ON, Canada; IEEE Signals and Computational Intelligence Chapter, Toronto Section, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, Keenan Research Centre, St. Michael's Hospital, Toronto, ON, Canada; Advanced Artificial Intelligence Lab, Toronto, ON, Canada.

Comment

Alexandre R Zlotta et al. Eur Urol. 2020 Aug.

. 2020 Aug;78(2):290-291.

doi: 10.1016/j.eururo.2020.04.010. Epub 2020 May 8.

¹ Division of Urology, Department of Surgery, Sinai Health System, University of Toronto, Toronto, ON, Canada; Surgical Oncology, Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: alexandre.zlotta@sinaihealth.ca.
² Department of Computer Science, Faculty of Science, Ryerson University, Toronto, ON, Canada; Healthcare AI and Analytics Theme, Institute for Biomedical Engineering, Science, and Technology (iBEST), Toronto, ON, Canada; IEEE Signals and Computational Intelligence Chapter, Toronto Section, Toronto, ON, Canada; Li Ka Shing Knowledge Institute, Keenan Research Centre, St. Michael's Hospital, Toronto, ON, Canada; Advanced Artificial Intelligence Lab, Toronto, ON, Canada.

No abstract available

Comment on

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P, Kartasalo K, Olsson H, Solorzano L, Delahunt B, Berney DM, Bostwick DG, Evans AJ, Grignon DJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, van der Kwast TH, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, Varma M, Zhou M, Lindberg J, Lindskog C, Ruusuvuori P, Wählby C, Grönberg H, Rantalainen M, Egevad L, Eklund M. Ström P, et al. Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8. Lancet Oncol. 2020. PMID: 31926806